Zhiping Li

China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 54 publications

Adjuvant Chemoradiotherapy or Chemotherapy After D2 Gastrectomy in Gastric Cancer: A Randomized Clinical Trial.

Adjuvant Chemoradiotherapy or Chemotherapy After D2 Gastrectomy in Gastric Cancer: A Randomized Clinical Trial.

Journal: JAMA network open

Published: June 15, 2026

Surufatinib plus toripalimab for patients with advanced solid tumors and disease progression after prior immunotherapy: an open-label multi-cohort phase 2 trial.

Surufatinib plus toripalimab for patients with advanced solid tumors and disease progression after prior immunotherapy: an open-label multi-cohort phase 2 trial.

Journal: Cancer immunology, immunotherapy : CII

Published: February 10, 2026

MASLD and CMRFs: Combination or Separation? An Open Exploration From the Perspective of All-Cause Mortality.

MASLD and CMRFs: Combination or Separation? An Open Exploration From the Perspective of All-Cause Mortality.

Journal: Liver international : official journal of the International Association for the Study of the Liver

Published: May 24, 2025

Ferroptosis at the intersection of radiotherapy and immunotherapy.

Ferroptosis at the intersection of radiotherapy and immunotherapy.

Journal: Cancer metastasis reviews

Published: April 16, 2025

Letter to the Editor: Different phenotypes of CMRFs lead to different pathophysiological processes among individuals with MASLD/MetALD.

Letter to the Editor: Different phenotypes of CMRFs lead to different pathophysiological processes among individuals with MASLD/MetALD.

Journal: Hepatology (Baltimore, Md.)

Published: January 07, 2025

Surufatinib in advanced neuroendocrine tumours: Final overall survival from two randomised, double-blind, placebo-controlled phase 3 studies (SANET-ep and SANET-p).

Surufatinib in advanced neuroendocrine tumours: Final overall survival from two randomised, double-blind, placebo-controlled phase 3 studies (SANET-ep and SANET-p).

Journal: European journal of cancer (Oxford, England : 1990)

Published: January 07, 2025

Is MetALD an independent risk factor of all-cause mortality? A meta-analysis of 164,694 individuals from the real world.

Is MetALD an independent risk factor of all-cause mortality? A meta-analysis of 164,694 individuals from the real world.

Journal: Journal of hepatology

Published: October 14, 2024

Is MASLD a real culprit for all-cause mortality? A meta-analysis and preliminary pathophysiology exploration in the real world.

Is MASLD a real culprit for all-cause mortality? A meta-analysis and preliminary pathophysiology exploration in the real world.

Journal: Journal of hepatology

Published: September 17, 2024

Spatial interactions of immune cells as potential predictors to efficacy of toripalimab plus chemotherapy in locally advanced or metastatic pancreatic ductal adenocarcinoma: a phase Ib/II trial.

Spatial interactions of immune cells as potential predictors to efficacy of toripalimab plus chemotherapy in locally advanced or metastatic pancreatic ductal adenocarcinoma: a phase Ib/II trial.

Journal: Signal transduction and targeted therapy

Published: August 12, 2024

Targeted therapy acts to sensitize stereotactic body radiotherapy for pulmonary oligometastases from colorectal cancer.

Targeted therapy acts to sensitize stereotactic body radiotherapy for pulmonary oligometastases from colorectal cancer.

Journal: Frontiers in oncology

Published: July 15, 2024

Letter to the Editor: Aspirin and GLP-1RAs-The missing confounders of empagliflozin for MASLD without diabetes mellitus?

Letter to the Editor: Aspirin and GLP-1RAs-The missing confounders of empagliflozin for MASLD without diabetes mellitus?

Journal: Hepatology (Baltimore, Md.)

Published: July 11, 2024

Comparison of Survival Between Different Histological Subtypes in Cervical Cancer Patients: A Retrospective and Propensity Score-matched Analysis.

Comparison of Survival Between Different Histological Subtypes in Cervical Cancer Patients: A Retrospective and Propensity Score-matched Analysis.

Journal: Journal of Cancer

Published: July 08, 2024

Showing 1-12 of 54

Last Updated: 09/26/2026